share_log

再鼎医药:国家批准瑞普替尼用于治疗ROS1阳性非小细胞肺癌患者

JRJ Finance ·  May 12 20:09

再鼎医药港交所公告,中国国家药品监督管理局批准瑞普替尼用于治疗ROS1阳性非小细胞肺癌患者。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment